Patent Infringement: Delhi High Court Restrains Zydus From Manufacturing Biologic Similar To 'Nivolumab' Cancer Drug
Nupur Thapliyal
19 July 2025 10:00 PM IST

Next Story
19 July 2025 10:00 PM IST
The Delhi High Court has restrained Zydus Lifesciences Limited from manufacturing, selling importing, exporting or dealing in any biologic which is similar to Nivolumab, a drug used to treat cancer, sold under the brand name “Opdivo.”Justice Mini Pushkarna passed the interim order in favour of Nivolumab's manufacturer company- E.R. Squibb and Sons LLC, in its patent infringement suit...
Your support helps us to bring you more content at
an affordable subscription scheme !!!
All payment options available
Nupur Thapliyal is a Principal Correspondent with LiveLaw, based in New Delhi. She reports from the Delhi High Court and trial courts in the national capital
